SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-079843
Filing Date
2023-07-11
Accepted
2023-07-11 09:22:06
Documents
14
Period of Report
2023-07-11
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2320976d1_8k.htm   iXBRL 8-K 46938
2 EXHIBIT 3.1 tm2320976d1_ex3-1.htm EX-3.1 37377
3 EXHIBIT 3.2 tm2320976d1_ex3-2.htm EX-3.2 72690
  Complete submission text file 0001104659-23-079843.txt   363261

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA isee-20230711.xsd EX-101.SCH 3021
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE isee-20230711_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isee-20230711_pre.xml EX-101.PRE 22363
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2320976d1_8k_htm.xml XML 3300
Mailing Address 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 8 SYLVAN WAY PARSIPPANY NJ 07054 (609) 474-6755
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 231081306
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences